Dr Thomas L Davis Iii, DO in Kingman, AZ - Otolaryngology

Dr Thomas L Davis Iii, DO is a Otolaryngology physician based in Kingman, Arizona. Dr Thomas L Davis Iii is licensed to practice in Arizona (license number 1743) and his current practice location is 3116 N Stockton Hill Rd, Kingman, Arizona. He can be reached at his office (for appointments etc.) via phone at (928) 753-3443.

NPI number for Dr Thomas L Davis Iii is 1093712721 and his current mailing address is 3116 N Stockton Hill Rd, Kingman, Arizona. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1093712721.

Contact Information

	Dr Thomas L Davis Iii, DO
	3116 N Stockton Hill Rd, Kingman, AZ 86401-4183
	(928) 753-3443
	(928) 753-4395

Physician's Profile

Full Name	Dr Thomas L Davis Iii
Gender	Male
Speciality	Otolaryngology
Location	3116 N Stockton Hill Rd, Kingman, Arizona
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1093712721
Provider Enumeration Date: 07/07/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Thomas L Davis Iii such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1093712721	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	1743 (Arizona)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Thomas L Davis Iii is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Thomas L Davis Iii, DO 3116 N Stockton Hill Rd, Kingman, AZ 86401-4183 Ph: (928) 753-3443	Dr Thomas L Davis Iii, DO 3116 N Stockton Hill Rd, Kingman, AZ 86401-4183 Ph: (928) 753-3443

News Archive

Tacere Therapeutics submits TT-034 clinical trial application to Recombinant DNA Advisory Committee

RNAi-based therapeutics company Benitec Biopharma Limited today announced that the company's wholly owned US subsidiary, Tacere Therapeutics Inc., has submitted an application to the US National Institutes of Health's Recombinant DNA Advisory Committee.

Abnormalities in eye movements and attention define risk for schizophrenia

A Binghamton University researcher has established a new framework to help determine whether individuals might be at risk for schizophrenia.

Research reveals that HPV infection is associated with higher subsequent risk of HIV infection

A study of 2,519 Kenyan men conducted by researchers at the University of North Carolina revealed that infection with the human papillomavirus (HPV) was associated with a higher subsequent risk of infection with HIV, a precursor to AIDS.

Simcere subsidiary receives Chinese SFDA approval to manufacture and market Palonosetron

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its subsidiary company Simcere Dongyuan Pharmaceutical Co., Ltd. has recently received SFDA new drug certification and registration approval to manufacture and market Palonosetron material and injections in China.

Dr Thomas L Davis Iii, DO - Otolaryngology in Kingman, AZ